Your session is about to expire
← Back to Search
Hormone Therapy Break for Metastatic Prostate Cancer (A-DREAM Trial)
A-DREAM Trial Summary
This triallooks at taking breaks from antiandrogen therapy in metastatic prostate cancer patients responding well to treatment. Doctors may be able to use this data to safely allow testosterone recovery.
A-DREAM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowA-DREAM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.A-DREAM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have an active second cancer, except for certain skin or superficial bladder cancers.My PSA level is 5 ng/ml or higher before starting intense hormone therapy.My scans showed cancer spread before starting hormone therapy.I am on hormone therapy for cancer using specific medications.I have not undergone surgical castration.My prostate cancer has spread to other parts of my body.I am currently on strong hormone therapy for advanced prostate cancer.I can take care of myself and am up and about more than 50% of my waking hours.I have had local treatment for prostate cancer and up to 6 cycles of docetaxel. Radiation for metastatic sites was also done.I have been on continuous testosterone suppression for my cancer for 18 to 24 months.My cancer has not spread to my liver or brain.I have not used experimental treatments for my prostate cancer.I have been treated with ARPI for at least 360 days, with short breaks allowed.I've had hormone therapy for cancer, but my cancer progressed after stopping it when my testosterone was normal or high.I haven't used ARPI before my current intense hormone therapy for prostate cancer.
- Group 1: Treatment (discontinue hormonal medication, follow up)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for this experiment in progress?
"Affirmative, the clinicaltrial.gov listing confirms that recruitment is presently underway for this medical study which was first posted on November 21st 2020 and last updated on December 14th 2022. In total, 75 patients are needed across a single centre."
Is the protocol of ceasing hormonal medication and continued monitoring officially endorsed by the FDA?
"Treatment (discontinue hormonal medication, follow up) was assigned a score of 2. This is because although there have been some studies that prove this intervention to be safe, no clinical trial data exists to suggest its efficacy."
What is the highest patient enrollment for this investigation?
"Affirmative. According to clinicaltrials.gov, this medical trial that began on November 21st 2022 is still actively seeking participants. 75 individuals are needed for the research and it will be conducted in 1 site."
Share this study with friends
Copy Link
Messenger